Saltar al contenido
Merck
  • Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity.

Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity.

Bioorganic & medicinal chemistry (2012-12-19)
Yun-Yun Xu, Yi Cao, Hailkuo Ma, Huan-Qiu Li, Gui-Zhen Ao
RESUMEN

A type of novel α,β-unsaturated cyclohexanone analogous, which designed based on the curcumin core structure, have been discovered as potential EGFR inhibitors. These compounds exhibit potent antiproliferative activity in two human tumor cell lines (Hep G2 and B16-F10). Among them, compounds I(3) and I(12) displayed the most potent EGFR inhibitory activity (IC(50) = 0.43 μM and 1.54 μM, respectively). Molecular docking of I(12) into EGFR TK active site was also performed. This inhibitor nicely fitting the active site might well explain its excellent inhibitory activity.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cyclohexanone, 99.8%
Sigma-Aldrich
Cyclohexanone, ACS reagent, ≥99.0%
Sigma-Aldrich
Cyclohexanone, ReagentPlus®, 99.8%
Sigma-Aldrich
Cyclohexanone, puriss. p.a., ≥99.5% (GC)
Supelco
Cyclohexanone, analytical standard
Sigma-Aldrich
Cyclohexanone, JIS special grade, ≥99.0%
Supelco
Cyclohexanone, Selectophore, ≥99.5%
Sigma-Aldrich
Cyclohexanone, SAJ first grade, ≥98.0%